BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15233909)

  • 21. MEN 1 and 2: the role of diagnostic imaging.
    Gollini P; Cataldi A; Fava C
    Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].
    Familiar C; Antón T; Moraga I; Ramos A; Marco A
    Endocrinol Nutr; 2011 Feb; 58(2):84-9. PubMed ID: 21339088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.
    Arao T; Okada Y; Tanikawa T; Inatomi H; Shuin T; Fujihira T; Yamashita H; Tanaka Y
    Endocr J; 2002 Apr; 49(2):181-8. PubMed ID: 12081237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEN 2 syndrome masquerading as MEN 1.
    Ezzat T; Paramesawaran R; Phillips B; Sadler G
    Ann R Coll Surg Engl; 2012 Sep; 94(6):e206-7. PubMed ID: 22943324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type I.
    Zarnegar R; Brunaud L; Clark OH
    Curr Treat Options Oncol; 2002 Aug; 3(4):335-48. PubMed ID: 12074770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pheochromocytomas and secreting paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pheochromocytoma: a review.
    Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
    Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
    Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
    Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
    Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
    J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
    Koch CA; Mauro D; Walther MM; Linehan WM; Vortmeyer AO; Jaffe R; Pacak K; Chrousos GP; Zhuang Z; Lubensky IA
    Endocr Pathol; 2002; 13(1):17-27. PubMed ID: 12114747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phaeochromocytoma: a ten-year survey.
    Loh KC; Shlossberg AH; Abbott EC; Salisbury SR; Tan MH
    QJM; 1997 Jan; 90(1):51-60. PubMed ID: 9093589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas--clinical diagnosis and imaging requirements].
    Auernhammer CJ; Engelhardt D; Göke B
    Radiologe; 2003 Apr; 43(4):265-74. PubMed ID: 12721642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pheochromocytoma: A three-decade clinical experience in a multicenter study.
    Iglesias P; Santacruz E; García-Sancho P; Marengo AP; Guerrero-Pérez F; Pian H; Fajardo C; Villabona C; Díez JJ
    Rev Clin Esp (Barc); 2021 Jan; 221(1):18-25. PubMed ID: 33998473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors].
    Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M
    Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
    Guo Z; Lloyd RV
    Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.
    Lairmore TC; Ball DW; Baylin SB; Wells SA
    Ann Surg; 1993 Jun; 217(6):595-601; discussion 601-3. PubMed ID: 8099474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of tumors of the adrenal medulla.
    Ilias I; Pacak K
    Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.